A Meta-Analysis of Adenosine A2A Receptor Antagonists on Levodopa-Induced Dyskinesia In Vivo

Neurobiology of l-DOPA induced dyskinesia and the novel therapeutic strategies

(2015) Sabeena Sharma et al.   BIOMEDICINE & PHARMACOTHERAPY

The adenosine A2A receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets

(2015) Shin-ichi Uchida et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease

(2014) Eva Schaeffer et al.   CNS DRUGS

Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: A review

(2014) Marla Rivera-Oliver et al.   LIFE SCIENCES

Effect of nicotine on l-dopa-induced dyskinesia in animal models of Parkinson’s disease: a systematic review and meta-analysis

(2014) Cheng-long Xie et al.   NEUROLOGICAL SCIENCES

A systematic review and meta-analysis of Baihui (GV20)-based scalp acupuncture in experimental ischemic stroke

(2014) Wen-wen Wang et al.   Scientific Reports

Continuous dopaminergic stimulation (CDS)-based treatment in Parkinson's disease patients with motor complications: A systematic review and meta-analysis

(2014) Cheng-long Xie et al.   Scientific Reports

Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats

(2014) Cheng-long Xie et al.   Scientific Reports

A2A receptor antagonists do not induce dyskinesias in drug-naive or l-dopa sensitized rats

(2013) N. Jones et al.   BRAIN RESEARCH BULLETIN

Meta-analysis of data from animal studies: A practical guide

(2013) H.M. Vesterinen et al.   JOURNAL OF NEUROSCIENCE METHODS

Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse

(2013) Veronica Francardo et al.   PARKINSONISM & RELATED DISORDERS

New pharmacological avenues for the treatment ofl-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors

(2012) Fabio Blandini et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Pramipexole Upregulates Dopamine Receptor D2 and D3 Expression in Rat Striatum

(2012) Naohito Tokunaga et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Animal models of l-DOPA–induced dyskinesia: an update on the current options

(2012) H. Iderberg et al.   NEUROSCIENCE

Adenosine A2A-Receptor Antagonism and Pathophysiology of Parkinson’s Disease and Drug-Induced Movement Disorders

(2011) Jaime Kulisevsky et al.   EUROPEAN NEUROLOGY

Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials

(2010) Petros Skapinakis et al.   BMC Neurology

Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease

(2010) Danqing Xiao et al.   BRAIN RESEARCH

CSC counteracts l-DOPA-induced overactivity of the corticostriatal synaptic ultrastructure and function in 6-OHDA-lesioned rats

(2010) Yi-xian Huang et al.   BRAIN RESEARCH

Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap

(2010) Paolo Calabresi et al.   LANCET NEUROLOGY

2009 Updated Method Guidelines for Systematic Reviews in the Cochrane Back Review Group

(2009) Andrea D. Furlan et al.   SPINE

Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations

(2008) Robert A. Hauser et al.   MOVEMENT DISORDERS